Business Archives

Empower Psychedelics is raising awareness for physical fitness as a key component of therapeutic recovery and rehabilitation

What investors need to know about the intellectual property behind medicine’s next big growth area

Math over Myth is your weekly source for psychedelic stock updates, including Compass Pathways and Revive Therapeutics

Math over Myth is your weekly update on psychedelic stocks and ETFs, including ATAI, COMPASS, Cybin, GH Research, Mindset, Numinus, and more

Get the latest news on psychedelic stocks Cybin, Numinus, MindMed, ATAI, Mindset, Braxia, Tryp, Irwin Naturals, and Revive

Track the monthly performance of the psychedelic stock sector with our Math over Myth Stock News Roundup

Psychedelic stock MindMed enters free fall as news of a private equity offering of common stock spooks retail investors

The psychedelic corporate shakeout continues as another company, HAVN Life Sciences, folds due to lack of cash flow

We interview Dr. Paul Thielking, Chief Science Officer of Numinus, about the use of psychedelics in palliative care and end of life care

In the latest installment of Math Over Myth we navigate psychedelic stock MindMed’s reverse split with Fibonacci numbers